---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-019049"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2022-09-29T23:59:59+00:00"
generated_at: "2026-06-23T06:43:50.223273+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director John Bolger resigns from Fulgent Genetics board effective Sept 24, 2022

## Summary
- John Bolger resigned as director and Audit Committee Chair on Sept 24, 2022.
- He also left the Compensation and Nominating & Corporate Governance Committees.
- Resignation not due to any disagreement with company operations, policies, or practices.
- No replacement has been announced.

## SEC filing metadata
- accession: 0000950170-22-019049
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2022-09-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017022019049/0000950170-22-019049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017022019049/flgt-20220924.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-019049
- JSON: https://secwatch.observer/filing/0000950170-22-019049.json
- Plain text: https://secwatch.observer/filing/0000950170-22-019049.txt

## Key facts
- Executive change
  John Bolger resigned as Director at Fulgent Genetics, Inc..
  - Action: resigned
  - Role: Director
  source text: On September 24, 2022, John Bolger notified the Board of Directors (the “Board”) of Fulgent Genetics, Inc. (the “Company”) of his decision to resign from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674930/000095017022019049/0000950170-22-019049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.